14 analysts have shared their evaluations of Zions Bancorp ZION during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 0 | 1 | 12 | 1 | 0 |
Last 30D | 0 | 0 | 7 | 0 | 0 |
1M Ago | 0 | 1 | 2 | 0 | 0 |
2M Ago | 0 | 0 | 2 | 0 | 0 |
3M Ago | 0 | 0 | 1 | 1 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $54.29, a high estimate of $59.00, and a low estimate of $49.00. This upward trend is apparent, with the current average reflecting a 3.49% increase from the previous average price target of $52.46.
Deciphering Analyst Ratings: An In-Depth Analysis
In examining recent analyst actions, we gain insights into how financial experts perceive Zions Bancorp. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
---|---|---|---|---|---|
Mike Mayo | Wells Fargo | Raises | Equal-Weight | $54.00 | $50.00 |
David Chiaverini | Wedbush | Raises | Neutral | $55.00 | $52.00 |
Christopher Mcgratty | Keefe, Bruyette & Woods | Raises | Market Perform | $56.00 | $53.00 |
Jon Arfstrom | RBC Capital | Raises | Sector Perform | $57.00 | $55.00 |
Ryan Nash | Goldman Sachs | Raises | Neutral | $59.00 | $52.00 |
Terry McEvoy | Stephens & Co. | Raises | Equal-Weight | $55.00 | $53.00 |
David George | Baird | Raises | Neutral | $55.00 | $52.00 |
Steven Alexopoulos | JP Morgan | Lowers | Neutral | $54.00 | $58.00 |
John Pancari | Evercore ISI Group | Lowers | Outperform | $56.00 | $58.00 |
Ken Zerbe | Morgan Stanley | Announces | Equal-Weight | $54.00 | - |
Jennifer Demba | Truist Securities | Lowers | Hold | $52.00 | $54.00 |
Ken Usdin | Jefferies | Lowers | Hold | $49.00 | $51.00 |
Mike Mayo | Wells Fargo | Lowers | Equal-Weight | $50.00 | $52.00 |
Ken Zerbe | Morgan Stanley | Raises | Underweight | $54.00 | $42.00 |
Key Insights:
- Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Zions Bancorp. This offers insight into analysts' perspectives on the current state of the company.
- Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Zions Bancorp compared to the broader market.
- Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Zions Bancorp's stock. This comparison reveals trends in analysts' expectations over time.
For valuable insights into Zions Bancorp's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Zions Bancorp analyst ratings.
Unveiling the Story Behind Zions Bancorp
Zions Bancorporation is a regional US bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions primarily focuses on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.
Zions Bancorp: Financial Performance Dissected
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Zions Bancorp's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -1.67%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Zions Bancorp's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 24.64%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Zions Bancorp's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.44%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Zions Bancorp's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.22%, the company may face hurdles in achieving optimal financial returns.
Debt Management: With a below-average debt-to-equity ratio of 0.1, Zions Bancorp adopts a prudent financial strategy, indicating a balanced approach to debt management.
What Are Analyst Ratings?
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.